← FDA Drug Approvals (Drugs@FDA)

POSACONAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2020-05-15

Drug application

FDA Application #

ANDA208773

Application type

Abbreviated New Drug Application (Generic)

Brand name

POSACONAZOLE

Generic name

POSACONAZOLE

Active ingredients

POSACONAZOLE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

HIKMA

Manufacturer

Hikma Pharmaceuticals USA Inc.

First approval

2020-05-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown